Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism-Reference-Cited by-同舟云学术

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism

Published:2020-06-16 Issue: Volume:12 Page:
ISSN:1663-4365
Container-title:Frontiers in Aging Neuroscience
language:
Short-container-title:Front. Aging Neurosci.

Author:

Cerroni Rocco,Liguori Claudio,Stefani Alessandro,Conti Matteo,Garasto Elena,Pierantozzi Mariangela,Mercuri Nicola B.,Bernardini Sergio,Fucci Giorgio,Massoud Renato

Publisher

Frontiers Media SA

Subject

Cognitive Neuroscience,Ageing

Reference58 articles.

1. Alexithymia and anhedonia in early Richardson’s syndrome and progressive supranuclear palsy with predominant parkinsonism;Assogna;Brain Behav.,2019

2. Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment;Balasa;J. Alzheimers Dis.,2014

3. Behavioral disorders in Alzheimer disease: a transcultural perspective;Binetti;Arch. Neurol.,1998

4. Donepezil for dementia due to Alzheimer’s disease;Birks;Cochrane Database Syst. Rev.,2018

5. Cerebrospinal fluid biomarkers in Alzheimer’s and Parkinson’s diseases-from pathophysiology to clinical practice;Blennow;Mov. Dis.,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies;Disease-a-Month;2024-08

2. Unveiling Parkinson’s disease through biomarker research: current insights and future prospects;Critical Reviews in Clinical Laboratory Sciences;2024-03-26

3. Nitrogen-doped carbon hollow trunk-like structure as a portable electrochemical sensor for noradrenaline detection in neuronal cells;Analytica Chimica Acta;2022-02

4. Metabolomic in Parkinson’s;Neurodegenerative Diseases Biomarkers;2021-10-16

5. CSF and PET biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis;2021-10-03